Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Arrowhead Research (ARWR)

Add to Watchlists
Create an Alert
12.62 -0.19  -1.48% NASDAQ Apr 24, 2:27PM BATS Real time Currency in USD
View Full Chart
ARWR Price Chart
View All Events

ARWR Events

Date Type Description
Feb 06 Misc AGM Event for Arrowhead Research Corp.
Feb 04 Misc Arrowhead Research Corporation Q1 2014 Earnings Conference Call
Feb 04 Earnings Arrowhead Research Corporation Q1 2014 Earnings Results. Estimate: -0.18.
Dec 18 Misc Fiscal 2013 Fourth Quarter and Year-End Financial Results Conference Call
Dec 18 Earnings Arrowhead to Report Fiscal 2013 Fourth Quarter and Year-end Financial Results. Estimate: -0.23.
Aug 07 Misc Arrowhead Announces Fiscal 2013 Third Quarter Financial Conference Call
Aug 07 Earnings Fiscal 2013 Third Quarter Financial Results. Estimate: -0.22.
May 09 Misc Arrowhead to Report Fiscal 2013 Second Quarter Financial Results and Conference Call
May 09 Earnings Fiscal 2013 Second Quarter Financial Results.
View All Performance Charts

ARWR Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Arrowhead Research is up 605.0% over the last year vs S&P 500 Total Return up 21.42%, Alnylam Pharmaceuticals up 119.6%, and Isis Pharmaceuticals up 58.62%.

Get Quote for

PDF Report for ARWR

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download ARWR Pro Report PDF
Advertisement

Portfolio Strategies Featuring ARWR

Did Arrowhead Research make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ARWR Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: September 30, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Research and Development in Biotechnology
  • NAICS Code: 541711
  • NAICS Industry: Scientific Research and Development Services
  • NAICS Industry Code: 5417
  • NAICS Sector: Professional, Scientific, and Technical Services
  • NAICS Sector Code: 54

Arrowhead Research Corporation is a biopharmaceutical company developing targeted RNAi therapeutics.

Recent Quotes

Symbol Price Chg Chg % Market Cap
ARWR 12.62 -0.19 -1.48% 500.85M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.